Syntheses and structure-activity relationships of novel retinoid X receptor agonists.

Basic Information

ID: ALA1131609

Journal: J Med Chem

Title: Syntheses and structure-activity relationships of novel retinoid X receptor agonists.

Authors: Hibi S, Kikuchi K, Yoshimura H, Nagai M, Tai K, Hida T.

Abstract: As part of our studies to develop novel retinoids with increased affinity and selectivity for the retinoid X receptor (RXR) subfamily, we have designed and synthesized a series of (E,E,E)-7-(1,2,3, 4-tetrahydroquinolin-6-yl)-7-alkyl-6-fluoro-3-methylhepta-2, 4, 6-trienoic acid derivatives. These tetrahydroquinolines, generated by introducing a polar N atom into the hydrophobic part of the retinoid skeleton, showed high binding affinity to RXRs. Addition of fluorine at the 6-position of the 2,4,6-trienoic acid moiety afforded compounds which elicit potent and selective transactivation of the RXRs. Compound 14b (ER-35794), which possesses an ethyl substituent at the 7-position and fluorine at the 6-position of the triene moiety, is one of the most potent and selective RXR agonists reported to date.

CiteXplore: 9703470

DOI: 10.1021/jm980058c

Patent ID: